Elucidata Company
Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
23580000.0
Founded Date:
2015-01-01
Employee Number:
51-100
Last Funding Type:
Series A
Investor Type:
info@elucidata.io
Investors Number:
4.0
Last Funding Date:
2022-09-27
Technology:
['BioTech & HealthTech']
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Industry:
Medical BioTech